# Adaptive Biotechnologies Corporation (ADPT): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/adpt for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Adaptive Biotechnologies Corporation, founded in 2009 and headquartered in Seattle, Washington (operating as Adaptive TCR Corporation until its name change in December 2011), is a commercial-stage entity focused on pioneering an immune medicine platform. This advanced platform is engineered for the precise diagnosis and effective treatment of a broad spectrum of illnesses. The company offers several core technological solutions. Its immunoSEQ platform, a foundational immunosequencing product, is vital for translational research and discovering novel prognostic and diagnostic markers. For co...

## Quote & Key Metrics

As of 2026-10-26:

| Metric | Value |
|---|---|
| Price | $26.27 USD |
| Market Cap | $4.19B |
| P/E (TTM) | — |
| EPS (TTM) | −$0.41 |
| 52-Week Range | $12.00 – $30.74 |
| Dividend Yield (TTM) | — |

## Dividend

ADPT has no dividend payment history in our records.

## Frequently Asked Questions

### What does Adaptive Biotechnologies Corporation do?

Adaptive Biotechnologies Corporation (ADPT) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is ADPT's market cap?

Adaptive Biotechnologies Corporation (ADPT) has a market capitalization of approximately $4.19 billion, as of October 26, 2026, based on the most recent share price and shares outstanding.

### Does ADPT pay a dividend?

No, Adaptive Biotechnologies Corporation (ADPT) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is ADPT profitable?

Adaptive Biotechnologies Corporation (ADPT) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has ADPT ever paid a dividend?

No. Dividend Data's records show no dividend payments from Adaptive Biotechnologies Corporation (ADPT). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/adpt
- Dividend history & safety: https://www.dividenddata.com/stocks/adpt/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/adpt/earnings
- Financial statements: https://www.dividenddata.com/stocks/adpt/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/adpt/valuation
- Peer comparison: https://www.dividenddata.com/stocks/adpt/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.